Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jules Rosen

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
The American Journal of Geriatric Pharmacotherapy|September 1, 2005
Population pharmacokinetics as a method to detect variable risperidone exposure in patients suffering from dementia with behavioral disturbancesRobert R Bies, Benoit H Mulsant, Jules Rosen, et al.
Journal of Geriatric Psychiatry and Neurology|June 27, 2002
Risperidone and 9-hydroxyrisperidone concentrations are not dependent on age or creatinine clearance among elderly subjectsRae Ann Maxwell, Robert A Sweet, Benoit H Mulsant, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 8, 2013
A comparison of the E-BEHAVE-AD, NBRS, and NPI in quantifying clinical improvement in the treatment of agitation and psychosis associated with dementiaZahinoor Ismail, Chetachi A Emeremni, Patricia R Houck, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 13, 2002
Verification of scale sub-domains in elderly patients with dementia: a confirmatory factor-analytic approachKari B Kastango, Yookyung Kim, Mary Amanda Dew, et al.
The Gerontologist|April 19, 2007
Perception gap in quality-of-life ratings: an empirical investigation of nursing home residents and caregiversVikas Mittal, Jules Rosen, Rahul Govind, et al.
The American Journal of Psychiatry|March 1, 2002
Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patientsBruce G Pollock, Benoit H Mulsant, Jules Rosen, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
The American Journal of Geriatric Pharmacotherapy|September 1, 2005
Population pharmacokinetics as a method to detect variable risperidone exposure in patients suffering from dementia with behavioral disturbancesRobert R Bies, Benoit H Mulsant, Jules Rosen, et al.
Journal of Geriatric Psychiatry and Neurology|June 27, 2002
Risperidone and 9-hydroxyrisperidone concentrations are not dependent on age or creatinine clearance among elderly subjectsRae Ann Maxwell, Robert A Sweet, Benoit H Mulsant, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 8, 2013
A comparison of the E-BEHAVE-AD, NBRS, and NPI in quantifying clinical improvement in the treatment of agitation and psychosis associated with dementiaZahinoor Ismail, Chetachi A Emeremni, Patricia R Houck, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 13, 2002
Verification of scale sub-domains in elderly patients with dementia: a confirmatory factor-analytic approachKari B Kastango, Yookyung Kim, Mary Amanda Dew, et al.
The Gerontologist|April 19, 2007
Perception gap in quality-of-life ratings: an empirical investigation of nursing home residents and caregiversVikas Mittal, Jules Rosen, Rahul Govind, et al.
The American Journal of Psychiatry|March 1, 2002
Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patientsBruce G Pollock, Benoit H Mulsant, Jules Rosen, et al.
Pageof 4